Insights

Innovative Allergy Treatments ROXALL Group specializes in allergen immunotherapy, a leading area with growing demand due to increasing allergy prevalence worldwide. This focus presents opportunities for partnerships or supply of raw materials, technology integration, or expanding distribution channels for their advanced therapies.

Global Expansion Potential With subsidiaries across Europe, Asia, and Latin America, ROXALL is strategically positioned for regional market penetration. Business development efforts could focus on regional collaborations, localized marketing, or distribution partnerships to leverage their international footprint.

Research & Innovation Focus Collaborations with research institutes in Bilbao and ongoing innovation efforts suggest opportunities to co-develop new allergy solutions or licensing of new treatments, appealing to companies invested in cutting-edge immunotherapy technology.

Diverse Product Portfolio Beyond immunotherapy, their subsidiary offers medical products for allergy symptom relief, expanding potential cross-selling and bundled offerings to healthcare providers and pharmacies actively seeking comprehensive allergy management solutions.

Tech Stack Compatibility ROXALL's use of multiple web technologies indicates a digitally mature organization open to digital collaboration, e-commerce, or telehealth platform integrations, which can facilitate streamlined communication, ordering, or educational initiatives for partners.

Similar companies to ROXALL Group

ROXALL Group Tech Stack

ROXALL Group uses 8 technology products and services including Google Hosted Libraries, Joomla, Osano, and more. Explore ROXALL Group's tech stack below.

  • Google Hosted Libraries
    Content Delivery Network
  • Joomla
    Content Management System
  • Osano
    Cookie Compliance
  • MooTools
    Javascript Frameworks
  • jQuery
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Bootstrap
    UI Frameworks
  • Nginx
    Web Servers

Media & News

ROXALL Group's Email Address Formats

ROXALL Group uses at least 2 format(s):
ROXALL Group Email FormatsExamplePercentage
FLast@roxall.deJDoe@roxall.de
75%
LastF@roxall.deDoeJ@roxall.de
25%

Frequently Asked Questions

Where is ROXALL Group's headquarters located?

Minus sign iconPlus sign icon
ROXALL Group's main headquarters is located at Meessen 20, Oststeinbek, 22113, DE. The company has employees across 2 continents, including EuropeAsia.

What is ROXALL Group's official website and social media links?

Minus sign iconPlus sign icon
ROXALL Group's official website is roxall.com and has social profiles on LinkedIn.

What is ROXALL Group's NAICS code?

Minus sign iconPlus sign icon
ROXALL Group's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ROXALL Group have currently?

Minus sign iconPlus sign icon
As of September 2025, ROXALL Group has approximately 201 employees across 2 continents, including EuropeAsia. Key team members include Cfo: G. L.Controller Financiero: J. V. V.Medical Management Director: O. P.. Explore ROXALL Group's employee directory with LeadIQ.

What industry does ROXALL Group belong to?

Minus sign iconPlus sign icon
ROXALL Group operates in the Pharmaceutical Manufacturing industry.

What technology does ROXALL Group use?

Minus sign iconPlus sign icon
ROXALL Group's tech stack includes Google Hosted LibrariesJoomlaOsanoMooToolsjQueryjQuery MigrateBootstrapNginx.

What is ROXALL Group's email format?

Minus sign iconPlus sign icon
ROXALL Group's email format typically follows the pattern of FLast@roxall.de. Find more ROXALL Group email formats with LeadIQ.

ROXALL Group

Pharmaceutical ManufacturingGermany201-500 Employees

ROXALL Group is an international pharmaceutical company based in Hamburg, Germany. Our core business is pharmaceuticals for allergen immunotherapy – the only causal allergy therapy renowned by the World Health Organization (WHO) that not only has the capacity to prevent an allergy turning into asthma but can also block the growth of new sensitizations. At ROXALL, we strive to constantly improve our treatments and to manufacture the highest quality products. As a result, we have made several and many of the most important innovations in this field.
ROXALL Group has subsidiaries in Europe, Asia and Latin America. The acquisition of the allergy-line of a pharmaceutical company in Bilbao, Spain, opened us a solid basis for future growth. Research in immuno- therapy has been the main focus of this company for more than 70 years.  Our team in Bilbao works closely with   leading research institutes, providing us with greater potential for developing new treatments. 
In addition to our allergen immune therapies, our subsidiary company DR. BECKMANN Pharma offers medical products that help ease many allergy symptoms. Our products range from nasal showers and ointments for sensitive skin to high quality allergen encasings and peak-flow meters.

Section iconCompany Overview

Headquarters
Meessen 20, Oststeinbek, 22113, DE
Website
roxall.com
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $25M$50M

    ROXALL Group's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $25M$50M

    ROXALL Group's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.